Why Wegovy Dose Appears Lower Than Mounjaro: The Science Behind Different Dosing
The fundamental reason why Wegovy doses appear numerically lower than Mounjaro relates to their distinct active ingredients and potency profiles. Wegovy contains semaglutide, a selective GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. These are entirely different molecules with separate dosing requirements—comparing their numbers directly would be like comparing milligrams of paracetamol to milligrams of ibuprofen. Wegovy's maintenance dose of 2.4mg weekly represents the optimal therapeutic level for semaglutide, whilst Mounjaro's higher numerical doses (up to 15mg) reflect tirzepatide's different molecular weight and receptor binding characteristics.
Understanding why Wegovy dose requirements differ from Mounjaro helps explain why both treatments can be equally effective despite the numerical difference. Clinical trials demonstrate that Wegovy's 2.4mg dose provides substantial weight management support when used alongside a reduced-calorie diet and increased physical activity. The STEP programme showed patients achieved an average of clinically studied weight loss at 68 weeks with Wegovy's dosing protocol. Both prescription-only medicines are available through EverydayMeds' GPhC-registered pharmacy (#9012878), allowing your prescriber to recommend the most suitable option based on your individual clinical profile rather than dose numbers alone.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
When comparing why Wegovy dose costs differ from Mounjaro, the pricing reflects each treatment's unique escalation schedule and supply requirements. Wegovy follows a 5-dose progression: £79.99 for 0.25mg starter (weeks 1-4), £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for 2.4mg maintenance (week 17 onwards). Our Getting Started bundles provide convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is available for £189.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
The question of why Wegovy dose pricing differs from Mounjaro becomes clearer when considering the complete treatment journey rather than individual pen costs. Our 3-pen Step-Up bundles offer extended supply security: the Intro Trio (0.25mg, 0.5mg & 1mg) provides 12 weeks of treatment for £299.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) covers the middle escalation phase for £369.99. For patients reaching maintenance, the Ultimate Stability Trio delivers three months of 2.4mg supply for £649.99. These bundles provide convenience through Reliable Supply and reduced ordering frequency, ensuring treatment continuity regardless of which dose level you require.
Clinical Evidence: Why Different Dosing Protocols Work
The clinical evidence explaining why Wegovy dose levels differ from Mounjaro comes from separate trial programmes designed specifically for each compound. Wegovy's efficacy was established through the STEP clinical programme, with STEP 1 demonstrating that patients achieved approximately 15% average weight loss at 68 weeks using the 2.4mg maintenance dose alongside lifestyle interventions. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, confirming that Wegovy's dosing protocol provides benefits beyond weight management.
Research by Wilding et al., published in NEJM 2021, established Wegovy's dose-escalation protocol as the optimal balance between efficacy and tolerability. The study found that the gradual progression from 0.25mg to 2.4mg over 16 weeks allowed patients to adapt to treatment whilst minimising gastrointestinal side effects. This evidence-based approach explains why Wegovy dose requirements follow a specific pattern rather than arbitrary numerical targets, ensuring each patient receives appropriate therapeutic support throughout their weight management journey.
How Wegovy Works: GLP-1 Mechanism and Dosing Requirements
Understanding how Wegovy works explains why its dose requirements differ from other weight management treatments and why direct numerical comparisons can be misleading. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone produced in your intestines when you eat. This mechanism works by binding to GLP-1 receptors in the brain, specifically in areas that control appetite and food intake, helping to reduce hunger signals and increase feelings of fullness after smaller meals. The treatment may also slow gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety between meals. Additionally, Wegovy can help reduce food cravings by affecting reward pathways in the brain, making it easier to stick to a reduced-calorie diet as part of your comprehensive weight management plan.
Ordering Process: Clinical Assessment to Delivery
Our streamlined ordering process ensures you receive the appropriate Wegovy dose following proper clinical assessment and prescriber review. The process begins with a comprehensive 3-minute online clinical questionnaire that covers your medical history, current medications, weight management goals, and any contraindications to GLP-1 receptor agonist therapy. Your assessment is then reviewed by our qualified prescribers within 3 working days (or 24 hours with our express service), who determine whether Wegovy is suitable and which starting dose is appropriate for your individual circumstances. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy and dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain product integrity. Throughout this process, you'll receive tracking information and can contact our clinical team with any questions about your treatment or dosing schedule.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
The practical differences between Wegovy and Mounjaro extend beyond dose numbers to important storage and handling considerations that affect daily use. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer significant travel convenience as they remain stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration—considerably longer than Mounjaro's 21-day room temperature limit. Both treatments use pre-filled injection pens, but Wegovy utilises Novo Nordisk's FlexTouch delivery system, which features dose escalation over 16 weeks from the initial 0.25mg dose to the 2.4mg maintenance level. The dose escalation schedule is mandatory and cannot be accelerated, as this gradual increase allows your body to adapt to the treatment whilst minimising potential gastrointestinal side effects. Each pen contains 4 doses for weekly administration, with clear dosing windows and safety features to prevent accidental overdose.
Why Wegovy vs Mounjaro Dose Comparison Matters for Treatment Choice
The question of why Wegovy dose appears lower than Mounjaro becomes particularly relevant when choosing between these treatments, as the numerical difference often creates confusion about relative effectiveness. However, the key consideration isn't the dose number but rather how each treatment's mechanism aligns with your individual physiology and treatment goals. Wegovy's selective GLP-1 action may be preferable for patients who respond well to appetite suppression through this single pathway, whilst Mounjaro's dual receptor approach might suit those requiring additional metabolic effects through GIP activation.
Both treatments are available through EverydayMeds, providing the unique advantage of having your prescriber compare both options based on your clinical profile rather than requiring you to visit separate providers. This comprehensive approach ensures you receive the most appropriate treatment regardless of dose numbers, with ongoing support throughout your weight management journey. Your prescriber can help determine which mechanism and dosing protocol best suits your individual circumstances, medical history, and weight management objectives.
Order Both Wegovy and Mounjaro Through EverydayMeds
EverydayMeds remains the only UK pharmacy offering both Wegovy and Mounjaro through a single platform, eliminating the confusion about why Wegovy dose numbers differ from Mounjaro and focusing instead on clinical suitability. Our qualified prescribers can recommend either treatment based on your individual assessment, with transparent pricing and no hidden fees regardless of which option proves most appropriate. New customers benefit from code FIRST40 applied at checkout, whilst returning patients use code DOSE25 for continued savings across both treatment options. Both prescription-only medicines are dispensed from our GPhC-registered pharmacy (#9012878) with the same high-quality cold-chain delivery and clinical support, ensuring consistent care regardless of your prescribed treatment. Contact our clinical team today to begin your assessment and discover which treatment option aligns best with your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026